Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year book value per share growth

Percentile
P17
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-25.56%
Q3 2025-29.61%
Q2 2025-28.94%
Q1 2025400.27%
Q4 2024-157.75%
Q3 2024-25.66%
Q2 2024179.66%
Q1 20243.77%
Q4 2023193.72%
Q3 2023-21.78%
Q2 2023-18.42%
Q1 2023-18.57%
Q4 2022-14.99%
Q3 2022-11.13%
Q2 2022-10.73%
Q1 2022-17.57%
Q4 2021-14.76%
Q3 202114.01%
Q2 2021-13.92%
Q1 2021-25.43%
Q4 2020288.76%
Q3 2020-166.62%
Q2 20200.00%
Q1 2020100.00%
Q4 20190.00%
Q3 20190.00%
Q2 20190.00%
Q1 20190.00%
Q2 20180.00%
Q1 20180.00%